about
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic HepatitisHepatitis E virus infection: Epidemiology and treatment implicationsEpidemiology of Hepatitis E Virus in European CountriesExtra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literatureChronic hepatitis E: A brief reviewAutochthonous Hepatitis E Virus Infection in Europe: A Matter of Concern for Public Health?Chronic hepatitis e virus infection and treatmentHepatitis E in Germany--an under-reported infectious diseaseMolecular Biology and Infection of Hepatitis E VirusHepatitis E Virus in Industrialized Countries: The Silent ThreatHepatitis E: the current state of play.Extra-hepatic manifestations of autochthonous hepatitis E infection.Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.Extrahepatic manifestations of hepatitis E virus.Hepatitis E-associated encephalopathy in a renal transplant recipient.Transmission, diagnosis, and management of hepatitis E: an updateSPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitisDiagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in EnglandNatural and experimental hepatitis E virus genotype 3-infection in European wild boar is transmissible to domestic pigs.Management of viral hepatitis in liver transplant recipientsQuantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model.Hepatitis E: an old infection with new implications.Evidence of MAPK-JNK1/2 activation by hepatitis E virus ORF3 protein in cultured hepatoma cells.Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.Serological evidence for a hepatitis e virus-related agent in goats in the United StatesTwo Uncommon Causes of Guillain-Barré Syndrome: Hepatitis E and Japanese EncephalitisDiagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort StudyMutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.Transmission of hepatitis E virus from rabbits to cynomolgus macaques.Hepatobiliary Quiz Answers-17 (2016).Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history?Hepatitis E virus infection.Host immune status and response to hepatitis E virus infection.Neuralgic amyotrophy and hepatitis E virus infection.Hepatitis e: the 'new kid on the block' or an old friend?Hepatitis E virus: what transplant physicians should know.Diagnosis of hepatitis E.
P2860
Q26740390-7A2214A5-A044-4618-A557-C675528F137BQ26777044-0F135877-CDA6-439B-85D6-2CA48A23F7E2Q26777824-E1F1D6E6-3A89-45E8-8FB3-C95C72313AD8Q26781682-8404A384-AA68-4399-BE69-A11653ED4A25Q26784271-B7ECC926-F54E-4816-9C84-75315F22CD60Q26996093-9F9BFA5B-C4B7-4A1A-9375-847888FBA5A8Q26996422-24CCF29F-752D-43F1-B9E9-600D5C588A1EQ27002938-E3A3C33C-5E55-4FC3-9546-8E8A0D4F5DF5Q28066101-01801894-3FF0-480B-AB85-6F7A120DE336Q28354374-C2AE7C4F-7119-4304-85BA-C631DBD95C5AQ30234939-5C7B77CB-B38B-4C61-94E4-EBC6F032B06FQ33418110-A180B76C-C341-40C7-B58C-DD078E5B86E6Q33420649-9E34D3DA-CDC6-424E-8F92-57A6A898A483Q33430954-84293041-CC9F-41BE-91E4-E8D48F5A2585Q33629182-D34FC394-D9F2-4D4A-9081-89B76F0850F3Q33734018-CA93492A-F784-448D-B625-806FBF2A5F91Q33769042-F66E53D6-B877-4D19-828C-B4E2358AFE9FQ34210568-9252D6A2-FCD4-45BD-BAFD-F6EBCD389DDAQ34568931-D07DA99D-0A7C-46D1-BC1E-E53EB0FEEA2BQ34779730-A68B7251-F01F-4E87-A0C3-D592F807FAE5Q34992525-C2FF990C-B6FB-43F0-BAF6-A37C5072505BQ35049128-1F2B05A7-9230-4A87-B02A-1D9B0D4737ABQ35211504-6819AE3A-9B40-49E1-8CA1-F4E03B2C84AEQ35943622-F8F05F84-265D-4557-B6E0-5D399ABC5211Q35960539-81524E4E-35AD-498B-8DD8-B3AB41C8B93BQ36009254-6214C5B3-7B07-44DC-A931-E491D81D0D89Q36212007-D88CFACF-255B-4B89-BA39-140021A81596Q36420009-1824C806-15D2-4F6A-9D3C-1B61A76A0B97Q36427184-B7BA51D0-87BE-4591-82F7-98AD4B146BB9Q36620859-6F63D4DA-ED1C-48A1-B1D4-4F3A05E356C1Q36644831-059BB745-4DC6-4E70-A24E-54B1E0A653CEQ36825146-4CF56DDB-AC04-43FE-8808-515ABAD87CA1Q36886795-63AF6DD5-A423-47C4-B053-4A4E0D34BCD7Q37098206-63E76035-249A-4109-9698-94D5FA32FE4DQ37544935-B49A5EA0-9399-487A-852D-3B9ED20AAFB8Q37544940-4B56E27D-4443-47E9-99A9-FAF1831F36A3Q37608880-F26C5590-B27F-4067-A696-17DC89CA1D19Q37630307-CECA9954-9C2D-4EBB-A376-F63DBBF569B2Q38006813-8B7270FE-11AB-4C04-B9D0-226F2C7EF55BQ38048600-95970B65-E68C-486C-9864-748C5E5D1E0F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatitis E virus and neurologic disorders.
@ast
Hepatitis E virus and neurologic disorders.
@en
Hepatitis E virus and neurologic disorders.
@nl
type
label
Hepatitis E virus and neurologic disorders.
@ast
Hepatitis E virus and neurologic disorders.
@en
Hepatitis E virus and neurologic disorders.
@nl
prefLabel
Hepatitis E virus and neurologic disorders.
@ast
Hepatitis E virus and neurologic disorders.
@en
Hepatitis E virus and neurologic disorders.
@nl
P2093
P2860
P50
P921
P356
P1476
Hepatitis E virus and neurologic disorders.
@en
P2093
Frances Keane
Jean Marie Peron
Jean Michel Mansuy
Laurent Prudhomme
Pascal Cintas
Richard P Bendall
Samreen Ijaz
P2860
P304
P356
10.3201/EID1702.100856
P577
2011-02-01T00:00:00Z